Hedges Asset Management LLC Crispr Therapeutics Ag Transaction History
Hedges Asset Management LLC
- $155 Million
- Q1 2025
A detailed history of Hedges Asset Management LLC transactions in Crispr Therapeutics Ag stock. As of the latest transaction made, Hedges Asset Management LLC holds 29,350 shares of CRSP stock, worth $1.3 Million. This represents 0.64% of its overall portfolio holdings.
Number of Shares
29,350
Previous 24,350
20.53%
Holding current value
$1.3 Million
Previous $958,000
4.18%
% of portfolio
0.64%
Previous 0.66%
Shares
14 transactions
Others Institutions Holding CRSP
# of Institutions
480Shares Held
64.2MCall Options Held
2.15MPut Options Held
1.92M-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl10.2MShares$452 Million3.73% of portfolio
-
Capital International Investors Los Angeles, CA6.07MShares$270 Million0.04% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD3.8MShares$169 Million0.09% of portfolio
-
Black Rock Inc. New York, NY2.78MShares$123 Million0.0% of portfolio
-
Nikko Asset Management Americas, Inc.2.54MShares$113 Million1.16% of portfolio
About CRISPR Therapeutics AG
- Ticker CRSP
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 78,009,296
- Market Cap $3.47B
- Description
- CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious diseases using its proprietary Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform. Its CRISPR/Cas9 is a gene editing technology that allows for precise directed changes to genomic DNA....